201
Views
40
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLESCellular and Molecular Biology

Effects of Naturally Occurring Polymethyoxyflavonoids on Cell Growth, P-Glycoprotein Function, Cell Cycle, and Apoptosis of Daunorubicin-Resistant T Lymphoblastoid Leukemia Cells

, , , , , & show all
Pages 220-229 | Published online: 28 Oct 2009

REFERENCES

  • Seedhouse, C.H.; Grundy, M.; White, P.; Li, Y.; Fisher, J.; Yakunina, D.; Moorman, A.V.; Hoy, T.; Russell, N.; Burnett, A.; Pallis, M. Sequential influences of leukemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Network acute myeloid leukemia 14 and 15 trials. Clin Cancer Res 2007, 13, 7059–7066.
  • Zhang, D.; Fan, D. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther 2007, 7, 1369–1378.
  • den Boer, M.L.; Pieters, R.; Kazemier, K.M., Janka-Schaub, G.E.; Henze, G.; Veerman, A.J. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia. Leukemia 1998, 12, 912–920.
  • Ikegawa, T.; Ushigome, F.; Koyabu, N.; Morimoto, S.; Shoyama, Y.; Naito, M.; Tsuruo, T.; Ohtani, H.; Sawada, Y. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett 2000, 160, 21–28.
  • Ikegawa, T.; Ohtani, H.; Koyabu, N.; Juichi, M.; Iwase, Y.; Ito, C.; Furukawa, H.; Naito, M.; Tsuruo, T.; Sawada, Y. Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett 2000, 177, 89–93.
  • Chaudhary, P.M.; Roninson, I.B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991, 66, 85–94.
  • Ludescher, C.; Gattringer, C.; Drach, J.; Hofmann, J.; Grunicke, H. Rapid functional assay for the detection of multidrug-resistant cells using the fluorescent dye rhodamine 123. Blood 1991, 78, 1385–1387.
  • Ludescher, C.; Thalar, J.; Drach, D.; Drach, J.; Spitaler, M.;Gattringer, C.; Huber, H.; Homann, J. Detection of activity of P-glycoprotein in human tumor samples using rhodamine 123. Br J Haematol 1992, 82, 161–168.
  • Neyfakh, A.A. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 1988, 174, 168–176.
  • Aslanian, A.M.; Fletcher, B.S.; Kilberg, M.S. Asparagine synthetase expression alone is sufficient to induce L-asparaginase resistance in MOLT-4 human leukemia cells. Biochem J 2001, 357, 321–328.
  • Flescher, E.; Rotem, R.; Kwon, P.; Azare, J.; Jaspers, I.; Cohen, D. Aspirin enhance multidrug resistance gene 1 expression in human MOLT-4 T lymphoma cells. Anticancer Res 2000, 20, 4441–4444.
  • Liu, Z.L.; Onda, K.; Tanaka, S.; Toma, T.; Hirano, T.; Oka, K.. Induction of multidrug resistance in MOLT-4 cells by anti-cancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Cancer Chemother Pharmacol 2002, 49, 391–397.
  • Hirano, T.; Oka, K.; Akiba, M. Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol 1989, 64, 69–78.
  • Hirano, T.; Abe, K.; Gotoh, M.; Oka, K. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 1995, 72, 1380–1388.
  • Ishiwa, J.; Sato, T.; Mimaki, Y.; Sashida, Y.; Yano, M.; Ito, A. A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. J Rheumatol 2000, 27, 20–25.
  • Kawaii, S.; Tomono, Y.; Katase, E.; Ogawa, K.; Yano, M. Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem 1999, 63, 896–899.
  • Ohtani, H.; Ikegawa, T.; Honda, Y.; Kohyama, N.; Morimoto, S.; Shoyama, Y.; Juichi, M.; Naito, M.; Tsuruo, T.; Sawada, Y. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. Pharm Res 2007, 24, 1936–1943.
  • Morley, K.L.; Ferguson, P.J.; Koropatnick, J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett 2007, 251, 168–178.
  • Nagase, H.; Omae, N.; Omori, A.; Nakagawasai, O.; Tadano, T.; Yokosuka, A.; Sashida, Y.; Mimaki, Y.; Yamakuni, T.; Ohizumi, Y. Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. Biochem Biophys Res Comm 2005, 337, 1330–1336.
  • Hu, X.-M.; Hirano, T.; Oka, K. Arsenic trioxide induces apoptosis equally to T lymphoblastoid leukemia MOLT-4 cells and P-gp expressing daunorubicin-resistant MOLT-4 cells. Cancer Chemother Pharmacol 2003, 51, 119–126.
  • Hu, X.M.; Hirano, T.; Oka, K. Arsenic trioxide induces apoptosis in MOLT-4 and its daunorubicin-resistant MOLT-4 cell lines via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Cancer Chemother Pharmacol 2003, 52, 47–58.
  • Efferth, T.; Konkimalla, V.B.; Wang, Y.F.; Sauerbrey, A.; Meinhardt, S.; Zintl, F.; Mattern, J.; Volm, M. Prediction of broad spectrum resistance of tumors towards anticancer drugs. Clin Cancer Res 2008, 14, 2405–2412.
  • Schrickx, J.A.; Fink-Gremmels, J. Implications of ABC transporters on the disposition of typical veterinary medicinal products. Eur J Pharmacol 2008, 585(2–3), 510–519.
  • Takano, K.; Tabata, Y.; Kitao, Y.; Murakami, R.; Suzuki, H.; Yamada, M.; Iinuma, M.; Yoneda, Y.; Ogawa, S.; Hori, O. Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin. Am J Physiol Cell Physiol 2007, 292, C353–361.
  • Pan, M.H.; Chen, W.J.; Lin-Shiau, S.Y.; Ho, C.T.; Lin, J.K. Tangeretin induces cell-cycle G1 arrest through inhibitingcyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 1992, 23, 1677–1684.
  • Hirano, T.; Gotoh, M.; Oka, K. Natural flavonoids and lignans as candidates for non-cytotoxic antiproliferative antileukemia. Life Sci 1994, 55, 1061–1069.
  • Psahoulia, F.H.; Drosopoulos, K.G.; Doubravska, L.; Andera, L.; Pintzas, A. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 2007, 6, 2591–2599.
  • Wang, J.; Yu, Y.; Hashimoto, F.; Sakata, Y.; Fujii, M.; Hou, D.X. Baicalein induces apoptosis through ROS-mediated mitochondrial dysfunction pathway in HL-60 cells. Int J Mol Med 2004, 14, 627–632.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.